AtriCure (Nasdaq: ATRC) will participate in the UBS Global Healthcare Conference on November 12, 2024, at 5:00 pm Pacific Standard Time, engaging in a fireside chat. Investors can access a live audio webcast of the presentation through the company's website. AtriCure specializes in surgical treatments for atrial fibrillation, left atrial appendage management, and post-operative pain management.